U.S. Disposable Syringes Market To Reach $3.69 Billion By 2030

U.S. Disposable Syringes Market Growth & Trends

The U.S. disposable syringes market size is expected to reach USD 3.69 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to register a 5.5% CAGR over the forecast period. The market is expected to grow due to increasing demand for vaccines along with growing adoption of self-administration of drugs, increasing adoption of safety syringes, and technological advancements, are supporting the market growth of U.S. disposable syringes.

The COVID-19 pandemic is anticipated to have a significant effect on the disposable syringe business in the U.S. The SARS-CoV-2 pandemic has caused a considerable increase in demand for hospital supplies, emergency supplies, medical disposables, and medications. Due to COVID-19, there has been an increase in COVID-19 vaccine production, which has led to an increase in demand for disposable syringes made in the U.S. In January 2020, in the U.S. alone, the Biomedical Advanced Research and Development Authority (BARDA) projected that 650 million to 850 million needles and syringes would be required to administer a vaccination. Therefore, the COVID-19 outbreak has immensely impacted medical disposables market and is considered to be a highly effective driver for U.S. disposable syringes market.

Moving forward, organizations like United Nations Children's Fund (UNICEF) aimed to purchase 1 billion syringes by the end of 2021 for COVID-19 vaccination operations in COVAX Facility nations. The syringes will all be of the auto-disable (AD) type, as permitted by the World Health Organization, notwithstanding the fact that the vaccines secured by the Facility may vary in their composition and storage needs. As a result, market growth is expected to accelerate in the near future.

 Request a free sample copy or view report summary: U.S. Disposable Syringes Market Report

U.S. Disposable Syringes Market Report Highlights

• On the basis of product, disposable syringes market has been segmented into conventional and safety syringes. Safety syringes segment held the largest share of around 64.5% in 2023 and is anticipated to witness a significant growth over the forecast period, owing to the various advantages, such as safety and easy to use, associated with this product.

• On the basis of application, the therapeutic injection segment held the largest market share of around 86.2% in 2023, owing to the increasing awareness towards blood donation and high prevalence of diseases such as HIV infection, tuberculosis malaria, and dengue in the country.

• California disposable syringes market is expected to witness the fastest growth rate over the forecast period. Factors that can be attributed to market growth include growing geriatric population, increasing number of surgeries, and rising expenditure on healthcare.

U.S. Disposable Syringes Market Segmentation

Grand View Research has segmented the U.S. disposable syringes market based on product, and application:

U.S. Disposable Syringes Product Outlook (Revenue USD Million; 2018 - 2030)

• Conventional Syringes

• Safety Syringes

  • Retractable Safety Syringes

  • Non-retractable Safety Syringes

U.S. Disposable Syringes Application Outlook (Revenue USD Million; 2018 - 2030)

• Immunization Injections

• Therapeutic Injections

List of Key Players in U.S. Disposable Syringes Market

• MEDTRONIC (Covidien)

• Nipro Corporation

• Fresenius Kabi AG

• Baxter International, Inc.

• B. Braun Melsungen AG

• BD

• Terumo Corporation

• Novo Nordisk

• UltiMed, Inc.

• Henke-Sass, Wolf

• Retractable Technologies

• Flextronics International Vita Needle Company